Immune tolerance network - clinical site monitoring group
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN266200400070C
- Awardee
-
PPD Development LP UEI ZANENSW6C665
- Awarding agency
-
NIAID DEA OA Acquisitions
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,002,687
Award facts
- Opportunity
-
- NIHNIAIDDAIT0446 Solicitation number
- Contract value 69% obligated
-
- $13,002,686.54 Current, with exercised options
- $18,792,842.54 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Cape Fear, NC 28401, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $329,186 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $409,533 | |
| Funding Only Action | $1,747,699 | |
| Funding Only Action | $1,967,311 | |
| Funding Only Action | $278,045 | |
| Funding Only Action | $1,797,101 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $18,963 | |
| Funding Only Action | $1,725,795 | |
| Funding Only Action | $1,693,943 | |
| Funding Only Action | $1,434,583 | |
| Original award | $1,600,528 |
Show all 16
About this award
This is a Cost Plus Fixed Fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific. The $18,792,842.54 contract is for the Immune Tolerance Network - Clinical Site Monitoring Group, which involves comprehensive clinical trial and research support services such as regulatory affairs, clinical site monitoring, data management, and analytical testing to support the development of vaccines, therapeutics, diagnostics, and medical countermeasures. The contract does not have a set-aside designation, and PPD has provided services for various NIH, Department of Defense, and Department of Health and Human Services initiatives, including COVID-19 studies, acute respiratory distress syndrome trials, and clinical site monitoring. PPD also holds several significant Indefinite Delivery Vehicles with NIAID and other agencies for a wide range of research and development activities.
Quick answers
Who was awarded contract HHSN266200400070C?
HHSN266200400070C was awarded to PPD Development LP by NIAID DEA OA Acquisitions (National Institutes of Health) on September 15, 2004.
How much is contract HHSN266200400070C worth?
The government has obligated $13,002,687 on HHSN266200400070C. Its potential value, with all options, is $18,792,843.
Was contract HHSN266200400070C competed?
The extent of competition for HHSN266200400070C was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award